FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels

por Trujillo-Alonso, Vicenta, Pratt, Edwin C., Zong, Hongliang, Lara-Martinez, Andres, Kaittanis, Charalambos, Rabie, Mohamed O., Longo, Valerie, Becker, Michael W., Roboz, Gail J., Grimm, Jan, Guzman, Monica L.
Publicado 2019